X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Strides Arcolab with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs MYLAN (US) - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES SHASUN LTD   MYLAN
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
MYLAN
Dec-14
STRIDES SHASUN LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,2754,060-   
Low Rs9182,861-   
Sales per share (Unadj.) Rs389.61,389.9-  
Earnings per share (Unadj.) Rs28.0167.4-  
Cash flow per share (Unadj.) Rs48.9269.5-  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs303.1690.9-  
Shares outstanding (eoy) m89.42378.37-   
Bonus/Rights/Conversions ESOPOI-  
Price / Sales ratio x2.82.5 113.0%   
Avg P/E ratio x39.220.7 189.7%  
P/CF ratio (eoy) x22.412.8 174.6%  
Price / Book Value ratio x3.65.0 72.2%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m98,0361,309,348 7.5%   
No. of employees `0005.825.0 23.2%   
Total wages/salary Rs m5,8810-   
Avg. sales/employee Rs Th6,005.921,035.5 28.6%   
Avg. wages/employee Rs Th1,014.00-   
Avg. net profit/employee Rs Th431.22,534.1 17.0%   
INCOME DATA
Net Sales Rs m34,834525,886 6.6%  
Other income Rs m1,686-3,065 -55.0%   
Total revenues Rs m36,520522,821 7.0%   
Gross profit Rs m6,428130,790 4.9%  
Depreciation Rs m1,87238,624 4.8%   
Interest Rs m2,26922,684 10.0%   
Profit before tax Rs m3,97366,417 6.0%   
Minority Interest Rs m0-272 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4702,793 16.8%   
Profit after tax Rs m2,50163,352 3.9%  
Gross profit margin %18.524.9 74.2%  
Effective tax rate %11.84.2 281.3%   
Net profit margin %7.212.0 59.6%  
BALANCE SHEET DATA
Current assets Rs m38,165462,324 8.3%   
Current liabilities Rs m30,402361,445 8.4%   
Net working cap to sales %22.319.2 116.2%  
Current ratio x1.31.3 98.1%  
Inventory Days Days7778 99.1%  
Debtors Days Days104107 97.4%  
Net fixed assets Rs m37,639121,662 30.9%   
Share capital Rs m89418,597 4.8%   
"Free" reserves Rs m26,2100-   
Net worth Rs m27,105261,417 10.4%   
Long term debt Rs m16,377390,532 4.2%   
Total assets Rs m81,1681,052,965 7.7%  
Interest coverage x2.83.9 70.0%   
Debt to equity ratio x0.61.5 40.4%  
Sales to assets ratio x0.40.5 85.9%   
Return on assets %5.98.2 71.9%  
Return on equity %9.224.2 38.1%  
Return on capital %12.113.6 88.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,3890-   
CASH FLOW
From Operations Rs m2,88169,128 4.2%  
From Investments Rs m-7,051-54,516 12.9%  
From Financial Activity Rs m3,382-18,215 -18.6%  
Net Cashflow Rs m-788-3,604 21.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 68.12 Rs / USD

Compare STRIDES SHASUN LTD With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STRIDES SHASUN LTD With: ALEMBIC PHARMA  UNICHEM LAB  PLETHICO PHARMA  AJANTA PHARMA  FRESENIUS KABI ONCO.  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jun 20, 2018 03:37 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS